Sarasin & Partners LLP boosted its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 65.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 926,449 shares of the financial services provider’s stock after acquiring an additional 367,121 shares during the period. Marsh & McLennan Companies accounts for about 1.8% of Sarasin & Partners LLP’s investment portfolio, making the stock its 22nd largest position. Sarasin & Partners LLP owned about 0.19% of Marsh & McLennan Companies worth $185,503,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of MMC. Trust Point Inc. lifted its stake in shares of Marsh & McLennan Companies by 18.8% during the 3rd quarter. Trust Point Inc. now owns 2,348 shares of the financial services provider’s stock valued at $473,000 after buying an additional 372 shares in the last quarter. Brown Lisle Cummings Inc. lifted its position in shares of Marsh & McLennan Companies by 10.3% in the third quarter. Brown Lisle Cummings Inc. now owns 20,347 shares of the financial services provider’s stock valued at $4,101,000 after acquiring an additional 1,902 shares in the last quarter. Mills Wealth Advisors LLC bought a new position in shares of Marsh & McLennan Companies in the third quarter worth about $278,000. Natural Investments LLC purchased a new position in Marsh & McLennan Companies in the 3rd quarter worth approximately $301,000. Finally, Cyndeo Wealth Partners LLC boosted its stake in Marsh & McLennan Companies by 1.8% in the 3rd quarter. Cyndeo Wealth Partners LLC now owns 18,958 shares of the financial services provider’s stock worth $3,821,000 after purchasing an additional 343 shares during the period. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Stock Down 0.7%
Shares of NYSE MMC opened at $184.48 on Friday. The stock has a market capitalization of $90.38 billion, a price-to-earnings ratio of 22.12, a P/E/G ratio of 3.17 and a beta of 0.75. Marsh & McLennan Companies, Inc. has a 12-month low of $174.18 and a 12-month high of $248.00. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 1.19. The firm’s 50-day moving average price is $184.25 and its 200-day moving average price is $199.89.
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 21,079 shares of the business’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $182.22, for a total transaction of $3,841,015.38. Following the transaction, the chief executive officer owned 87,681 shares in the company, valued at $15,977,231.82. The trade was a 19.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.35% of the stock is owned by insiders.
Wall Street Analyst Weigh In
MMC has been the topic of several research analyst reports. JPMorgan Chase & Co. raised shares of Marsh & McLennan Companies from a “neutral” rating to an “overweight” rating and lowered their target price for the stock from $248.00 to $242.00 in a report on Thursday, October 9th. The Goldman Sachs Group upgraded shares of Marsh & McLennan Companies from a “sell” rating to a “neutral” rating and decreased their price target for the stock from $200.00 to $195.00 in a research note on Monday, October 20th. Wells Fargo & Company cut their price objective on Marsh & McLennan Companies from $222.00 to $212.00 and set an “equal weight” rating for the company in a research report on Friday, October 17th. Weiss Ratings reiterated a “hold (c)” rating on shares of Marsh & McLennan Companies in a research report on Friday, October 31st. Finally, UBS Group cut their price target on Marsh & McLennan Companies from $258.00 to $257.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and an average target price of $222.35.
Read Our Latest Stock Analysis on MMC
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- Best Aerospace Stocks Investing
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- How to Invest in the FAANG Stocks
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- 3 Small Caps With Big Return Potential
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
